| Product Code: ETC12962850 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of naltrexone and buprenorphine to Finland in 2024 show a steady growth trend with a Compound Annual Growth Rate (CAGR) of 2.88% from 2020 to 2024. The top countries exporting to Finland include Germany, Netherlands, Denmark, Sweden, and the USA. Despite the low concentration levels in 2023, the Herfindahl-Hirschman Index (HHI) improved to a low concentration in 2024. The marginal growth rate of 0.14% from 2023 to 2024 indicates a stable market for these pharmaceutical imports in Finland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Naltrexone Buprenorphine Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Finland Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Finland Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.6 Finland Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Finland Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Finland Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.9 Finland Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 Finland Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the importance of medication-assisted treatment |
4.2.2 Government initiatives and policies promoting the use of naltrexone and buprenorphine for addiction treatment |
4.2.3 Rising opioid abuse cases leading to higher demand for medications like naltrexone and buprenorphine |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the prescription and distribution of naltrexone and buprenorphine |
4.3.2 Stigma associated with medication-assisted treatment for opioid addiction |
4.3.3 Limited access to healthcare facilities providing naltrexone and buprenorphine treatment in certain regions |
5 Finland Naltrexone Buprenorphine Market Trends |
6 Finland Naltrexone Buprenorphine Market, By Types |
6.1 Finland Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2021 - 2031F |
6.1.3 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2021 - 2031F |
6.1.4 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2021 - 2031F |
6.1.5 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2021 - 2031F |
6.1.6 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2021 - 2031F |
6.1.7 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2021 - 2031F |
6.2 Finland Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031F |
6.2.3 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2021 - 2031F |
6.2.4 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2021 - 2031F |
6.2.5 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2021 - 2031F |
6.2.6 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2021 - 2031F |
6.3 Finland Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2021 - 2031F |
6.3.3 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2021 - 2031F |
6.3.4 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2021 - 2031F |
6.3.5 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2021 - 2031F |
6.3.6 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.4 Finland Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.4.4 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.5 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.6 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Finland Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5.3 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.5.4 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.5.5 Finland Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2021 - 2031F |
6.5.6 Finland Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2021 - 2031F |
7 Finland Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Finland Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Finland Naltrexone Buprenorphine Market Imports from Major Countries |
8 Finland Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in prescribing naltrexone and buprenorphine |
8.2 Percentage of opioid addiction patients receiving medication-assisted treatment |
8.3 Average waiting time for patients seeking naltrexone and buprenorphine treatment |
9 Finland Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Finland Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.2 Finland Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Finland Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Finland Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.5 Finland Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
10 Finland Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Finland Naltrexone Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Finland Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here